{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T01:37:06Z","timestamp":1776735426105,"version":"3.51.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-026-03616-3","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:44:14Z","timestamp":1773366254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between anti-citrullinated peptide antibodies and subclinical interstitial lung disease in community-dwelling adults: the multi-ethnic study of atherosclerosis"],"prefix":"10.1186","volume":"27","author":[{"given":"Jenna V.","family":"Lanz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Hughes-Austin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna J.","family":"Podolanczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary M.","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh","family":"Raghu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"John D.","family":"Newell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Jubal R.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Hrudaya","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushilkumar K.","family":"Sonavane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon T.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine Kim","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Graham","family":"Barr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elana J.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"7","key":"3616_CR1","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S2213-2600(14)70101-8","volume":"2","author":"G Raghu","year":"2014","unstructured":"Raghu G, et al. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11. Lancet Respir Med. 2014;2(7):566\u201372.","journal-title":"Lancet Respir Med"},{"issue":"7","key":"3616_CR2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1164\/rccm.200702-254OC","volume":"176","author":"IO Rosas","year":"2007","unstructured":"Rosas IO, et al. Early interstitial lung disease in familial pulmonary fibrosis. Am J Respir Crit Care Med. 2007;176(7):698\u2013705.","journal-title":"Am J Respir Crit Care Med"},{"issue":"23","key":"3616_CR3","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1056\/NEJMoa1216076","volume":"368","author":"GM Hunninghake","year":"2013","unstructured":"Hunninghake GM, et al. MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med. 2013;368(23):2192\u2013200.","journal-title":"N Engl J Med"},{"issue":"2","key":"3616_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","volume":"168","author":"BR Gochuico","year":"2008","unstructured":"Gochuico BR, et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med. 2008;168(2):159\u201366.","journal-title":"Arch Intern Med"},{"issue":"7","key":"3616_CR5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S2213-2600(20)30168-5","volume":"8","author":"H Hatabu","year":"2020","unstructured":"Hatabu H, et al. Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society. Lancet Respir Med. 2020;8(7):726\u201337.","journal-title":"Lancet Respir Med"},{"issue":"10","key":"3616_CR6","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJMoa1007285","volume":"364","author":"GR Washko","year":"2011","unstructured":"Washko GR, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med. 2011;364(10):897\u2013906.","journal-title":"N Engl J Med"},{"issue":"7","key":"3616_CR7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1001\/jama.2016.0518","volume":"315","author":"RK Putman","year":"2016","unstructured":"Putman RK, et al. Association Between Interstitial Lung Abnormalities and All-Cause Mortality. JAMA. 2016;315(7):672\u201381.","journal-title":"JAMA"},{"issue":"1","key":"3616_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1378\/chest.13-1394","volume":"146","author":"TJ Doyle","year":"2014","unstructured":"Doyle TJ, et al. Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis. Chest. 2014;146(1):41\u201350.","journal-title":"Chest"},{"issue":"4","key":"3616_CR9","doi-asserted-by":"publisher","first-page":"1902262","DOI":"10.1183\/13993003.02262-2019","volume":"55","author":"EJ Bernstein","year":"2020","unstructured":"Bernstein EJ, et al. Antinuclear antibodies and subclinical interstitial lung disease in community-dwelling adults: the MESA study. Eur Respir J. 2020;55(4):1902262.","journal-title":"Eur Respir J"},{"issue":"12","key":"3616_CR10","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1136\/thoraxjnl-2016-208932","volume":"71","author":"EJ Bernstein","year":"2016","unstructured":"Bernstein EJ, et al. Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis. Thorax. 2016;71(12):1082\u201390.","journal-title":"Thorax"},{"issue":"9","key":"3616_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/aje\/kwf113","volume":"156","author":"DE Bild","year":"2002","unstructured":"Bild DE, et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002;156(9):871\u201381.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"3616_CR12","doi-asserted-by":"publisher","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","volume":"7","author":"J Sokolove","year":"2012","unstructured":"Sokolove J, et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE. 2012;7(5):e35296.","journal-title":"PLoS ONE"},{"issue":"10","key":"3616_CR13","doi-asserted-by":"publisher","first-page":"e0291967","DOI":"10.1371\/journal.pone.0291967","volume":"18","author":"JM Hughes-Austin","year":"2023","unstructured":"Hughes-Austin JM, et al. Serum reactivity to citrullinated protein\/peptide antigens and left ventricular structure and function in the Multi-Ethnic Study of Atherosclerosis (MESA). PLoS ONE. 2023;18(10):e0291967.","journal-title":"PLoS ONE"},{"issue":"8","key":"3616_CR14","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","volume":"73","author":"JT Giles","year":"2014","unstructured":"Giles JT, et al. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease. Ann Rheum Dis. 2014;73(8):1487\u201394.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3616_CR15","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s40744-021-00362-4","volume":"8","author":"T Khan","year":"2021","unstructured":"Khan T, et al. A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Bronchiectasis. Rheumatol Ther. 2021;8(4):1463\u201375.","journal-title":"Rheumatol Ther"},{"issue":"3","key":"3616_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/BOR.0000000000000380","volume":"29","author":"C Johnson","year":"2017","unstructured":"Johnson C. Recent advances in the pathogenesis, prediction, and management of rheumatoid arthritis-associated interstitial lung disease. Curr Opin Rheumatol. 2017;29(3):254\u20139.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"3616_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1055\/s-0034-1371542","volume":"35","author":"F Lake","year":"2014","unstructured":"Lake F, Proudman S. Rheumatoid arthritis and lung disease: from mechanisms to a practical approach. Semin Respir Crit Care Med. 2014;35(2):222\u201338.","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"3616_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.rmed.2015.01.011","volume":"109","author":"PR Bauer","year":"2015","unstructured":"Bauer PR, et al. Influence of autoimmune biomarkers on interstitial lung diseases: A tertiary referral center based case-control study. Respir Med. 2015;109(3):397\u2013405.","journal-title":"Respir Med"},{"issue":"7","key":"3616_CR19","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.rmed.2012.03.006","volume":"106","author":"A Fischer","year":"2012","unstructured":"Fischer A, et al. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med. 2012;106(7):1040\u20137.","journal-title":"Respir Med"},{"key":"3616_CR20","doi-asserted-by":"publisher","first-page":"102400","DOI":"10.1016\/j.jaut.2019.102400","volume":"110","author":"HU Scherer","year":"2020","unstructured":"Scherer HU, H\u00e4upl T, Burmester GR. The etiology of rheumatoid arthritis. J Autoimmun. 2020;110:102400.","journal-title":"J Autoimmun"},{"issue":"4","key":"3616_CR21","doi-asserted-by":"publisher","first-page":"e0153024","DOI":"10.1371\/journal.pone.0153024","volume":"11","author":"C Johnson","year":"2016","unstructured":"Johnson C, et al. Smoking and Subclinical ILD in RA versus the Multi-Ethnic Study of Atherosclerosis. PLoS ONE. 2016;11(4):e0153024.","journal-title":"PLoS ONE"},{"issue":"1","key":"3616_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/rheumatology\/kel202","volume":"46","author":"T Bongartz","year":"2007","unstructured":"Bongartz T, et al. Citrullination in extra-articular manifestations of rheumatoid arthritis. Rheumatology (Oxford). 2007;46(1):70\u20135.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"3616_CR23","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1136\/ard.2007.075192","volume":"67","author":"D Makrygiannakis","year":"2008","unstructured":"Makrygiannakis D, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis. 2008;67(10):1488.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3616_CR24","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1378\/chest.114.3.801","volume":"114","author":"EL Greidinger","year":"1998","unstructured":"Greidinger EL, et al. African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest. 1998;114(3):801\u20137.","journal-title":"Chest"},{"issue":"6","key":"3616_CR25","doi-asserted-by":"publisher","first-page":"1800255","DOI":"10.1183\/13993003.00255-2018","volume":"51","author":"A Adegunsoye","year":"2018","unstructured":"Adegunsoye A, et al. African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis. Eur Respir J. 2018;51(6):1800255.","journal-title":"Eur Respir J"},{"issue":"3","key":"3616_CR26","doi-asserted-by":"publisher","first-page":"e232427","DOI":"10.1001\/jamanetworkopen.2023.2427","volume":"6","author":"A Adegunsoye","year":"2023","unstructured":"Adegunsoye A, et al. Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US Adults. JAMA Netw Open. 2023;6(3):e232427\u2013232427.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"3616_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10067-019-04575-5","volume":"39","author":"C Mendes","year":"2020","unstructured":"Mendes C, et al. Clinical and laboratory features of African-Brazilian patients with systemic sclerosis. Clin Rheumatol. 2020;39(1):9\u201317.","journal-title":"Clin Rheumatol"},{"issue":"9","key":"3616_CR28","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1002\/art.34482","volume":"64","author":"V Steen","year":"2012","unstructured":"Steen V, et al. A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis. Arthritis Rheum. 2012;64(9):2986\u201394.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3616_CR29","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3899\/jrheum.180042","volume":"46","author":"H Al-Sheikh","year":"2019","unstructured":"Al-Sheikh H, Ahmad Z, Johnson SR. Ethnic Variations in Systemic Sclerosis Disease Manifestations, Internal Organ Involvement, and Mortality. J Rheumatol. 2019;46(9):1103\u20138.","journal-title":"J Rheumatol"},{"issue":"3","key":"3616_CR30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/1529-0131(199904)42:3<465::AID-ANR11>3.0.CO;2-Y","volume":"42","author":"M Kuwana","year":"1999","unstructured":"Kuwana M, et al. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum. 1999;42(3):465\u201374.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3616_CR31","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/art.22532","volume":"57","author":"TA McNearney","year":"2007","unstructured":"McNearney TA, et al. Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum. 2007;57(2):318\u201326.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"3616_CR32","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1007\/s10067-019-04760-6","volume":"38","author":"IM McFarlane","year":"2019","unstructured":"McFarlane IM, et al. Assessment of interstitial lung disease among black rheumatoid arthritis patients. Clin Rheumatol. 2019;38(12):3413\u201324.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"3616_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.reuma.2019.06.001","volume":"17","author":"N Mena-V\u00e1zquez","year":"2021","unstructured":"Mena-V\u00e1zquez N, et al. Analysis of Clinical-Analytical Characteristics in Patients with Rheumatoid Arthritis and Interstitial Lung Disease: Case-Control Study. Reumatol Clin (Engl Ed). 2021;17(4):197\u2013202.","journal-title":"Reumatol Clin (Engl Ed)"},{"issue":"4","key":"3616_CR34","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1513\/AnnalsATS.202006-590OC","volume":"18","author":"JG Natalini","year":"2021","unstructured":"Natalini JG, et al. Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of U.S. Veterans. Ann Am Thorac Soc. 2021;18(4):598\u2013605.","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"3616_CR35","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1007\/s10067-021-05808-2","volume":"40","author":"S Xie","year":"2021","unstructured":"Xie S, et al. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis. Clin Rheumatol. 2021;40(11):4533\u201343.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"3616_CR36","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/1529-0131(199904)42:3<415::AID-ANR4>3.0.CO;2-Z","volume":"42","author":"SE Gabriel","year":"1999","unstructured":"Gabriel SE, Crowson CS, O\u2019Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955\u20131985. Arthritis Rheum. 1999;42(3):415\u201320.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3616_CR37","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1053\/berh.2002.0257","volume":"16","author":"DP Symmons","year":"2002","unstructured":"Symmons DP. Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Pract Res Clin Rheumatol. 2002;16(5):707\u201322.","journal-title":"Best Pract Res Clin Rheumatol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03616-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03616-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03616-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:44:02Z","timestamp":1776732242000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03616-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3616"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03616-3","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. This study was approved by the Institutional Review Boards at each of the six enrolling centers (Columbia University; Johns Hopkins University; Northwestern University; University of California, Los Angeles; University of Minnesota; Wake Forest University) and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AJP reports research funding from NHLBI and the American Lung Association, receives consulting fees from Boehringer Ingelheim, Regeneron, and Imvaria and received honoraria from the National Association of Continuing Education. JSK receives grant funding from NHLBI, Chest, and Pulmonary Fibrosis Foundation. MMS reports consulting fees from Boehringer Ingelheim and Genentech, and honoraria from Genentech, France Foundation, and Peer View. GR receives grant funding from the NIH, consulting fees from Boehringer Ingelheim, Bellerophon Therapeutics, Blade Therapeutics, Bristol Myers Squibb, Gilead, Electra Therapeutics, Fibrogen, Nitto, Veracyte, Zambon, Roche-Genentech, royalties from UpToDate and sits on advisory boards for Avalyn Pharma and the Pulmonary Fibrosis Foundation. EAH receives grant funding from the NIH, sits on an advisory board for Siemens Healthineers and has stock options in VIDA Diagnostics. JDN reports grant funding from NIH, consulting fees, honoraria, stocks and patents from VIDA Diagnostics and royalties and honoraria from Elsevier. JRW reports honoraria from Boehringer Ingelheim. SKS reports grant funding from NIH. CKG reports grant funding from NIH and DOD. RGB reports research funding from the NIH and COPD Foundation, and receives consulting fees from the Environmental Protection Agency and the American Lung Association. EJB receives grant funding from the NIH and DOD; research support from AstraZeneca, aTYR, Boehringer Ingelheim, Cabaletta Bio, Bristol-Meyers Squibb, Synthekine; and consultancy fees from Boehringer Ingelheim and Synthekine.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}